HGS004
HGS004 is a humanized IgG4 monoclonal antibody inhibitor targeting CCR5. HGS004 has potent antivival activity against a diverse panel of CCR5-tropic HIV-1 and durg (such as Maraviroc ) -resistant strains. HGS004 can be used for HIV-1 infections research[1][2].
Product Specifications
UNSPSC
12352100
Target
CCR; HIV
Related Pathways
Anti-infection; GPCR/G Protein; Immunology/Inflammation
Applications
COVID-19-anti-virus
Field of Research
Infection
References & Citations
[1]Latinovic O, et al. CCR5 antibodies HGS004 and HGS101 preferentially inhibit drug-bound CCR5 infection and restore drug sensitivity of Maraviroc-resistant HIV-1 in primary cells. Virology. 2011 Mar 1;411 (1) :32-40. |[2]Lalezari J, et al. Safety, pharmacokinetics, and antiviral activity of HGS004, a novel fully human IgG4 monoclonal antibody against CCR5, in HIV-1-infected patients. J Infect Dis. 2008 Mar 1;197 (5) :721-7.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
CCR5; HIV-1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470026-500 1x 500 µL
ACTH (Adrenocorticotrophic Hormone) (AH26), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401073-500 1x 500 µL
HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471887-500 1x 500 µL
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (MUC1/1887R), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC882329-500 1x 500 µL
MyoD1 (Rhabdomyosarcoma Marker) (rMYD712), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940470-100 1x 100 µL
CD45 / LCA (2B11), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details